These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 9625142)
1. Acute hepatitis, autoimmune hemolytic anemia, and erythroblastocytopenia induced by ceftriaxone. Longo F; Hastier P; Buckley MJ; Chichmanian RM; Delmont JP Am J Gastroenterol; 1998 May; 93(5):836-7. PubMed ID: 9625142 [TBL] [Abstract][Full Text] [Related]
2. Ceftriaxone induced immune hemolytic anemia: detection of drug-dependent antibody by ex-vivo antigen in urine. Kim S; Song KS; Kim HO; Lee HM Yonsei Med J; 2002 Jun; 43(3):391-4. PubMed ID: 12089751 [TBL] [Abstract][Full Text] [Related]
3. Fatal immune haemolysis due to a degradation product of ceftriaxone. Meyer O; Hackstein H; Hoppe B; Göbel FJ; Bein G; Salama A Br J Haematol; 1999 Jun; 105(4):1084-5. PubMed ID: 10554824 [TBL] [Abstract][Full Text] [Related]
4. Dydrogesterone-induced hepatitis and autoimmune hemolytic anemia. Altintaş E; Oğuz D; Kaçar S; Ozderin Y; Sezgin O; Zengin NI Turk J Gastroenterol; 2004 Mar; 15(1):49-52. PubMed ID: 15264122 [TBL] [Abstract][Full Text] [Related]
5. Ceftriaxone-induced hemolytic anemia and hepatitis in an adolescent with hemoglobin SC disease. Bell MJ; Stockwell DC; Luban NL; Shirey RS; Shaak L; Ness PM; Wong EC Pediatr Crit Care Med; 2005 May; 6(3):363-6. PubMed ID: 15857541 [TBL] [Abstract][Full Text] [Related]
6. Ceftriaxone-induced hemolytic anemia in a child successfully managed with intravenous immunoglobulin. Vehapoğlu A; Göknar N; Tuna R; Çakır FB Turk J Pediatr; 2016; 58(2):216-219. PubMed ID: 27976566 [TBL] [Abstract][Full Text] [Related]
7. Ceftriaxone-induced immune hemolytic anemia as a life-threatening complication of antibiotic treatment of 'chronic Lyme disease'. De Wilde M; Speeckaert M; Callens R; Van Biesen W Acta Clin Belg; 2017 Apr; 72(2):133-137. PubMed ID: 27169474 [TBL] [Abstract][Full Text] [Related]
8. Ceftriaxone-induced immune hemolytic anemia. Neuman G; Boodhan S; Wurman I; Koren G; Bitnun A; Kirby-Allen M; Ito S Ann Pharmacother; 2014 Dec; 48(12):1594-604. PubMed ID: 25163809 [TBL] [Abstract][Full Text] [Related]
10. Ceftriaxone-induced drug reaction mimicking acute splenic sequestration crisis in a child with hemoglobin SC disease. Van Buren NL; Gorlin JB; Reed RC; Gottschall JL; Nelson SC Transfusion; 2018 Apr; 58(4):879-883. PubMed ID: 29473172 [TBL] [Abstract][Full Text] [Related]
11. Unusual serological findings associated with ceftriaxone-induced immune hemolytic anemia in a child with disseminated low-grade glioma. Pecker LH; Timsar A; Pary PP; Denomme GA; Criss VR; Luban NL; Hwang EI; Wong EC Pediatr Blood Cancer; 2016 Oct; 63(10):1852-5. PubMed ID: 27304608 [TBL] [Abstract][Full Text] [Related]
12. Serologic characteristics of ceftriaxone antibodies in 25 patients with drug-induced immune hemolytic anemia. Arndt PA; Leger RM; Garratty G Transfusion; 2012 Mar; 52(3):602-12. PubMed ID: 21880048 [TBL] [Abstract][Full Text] [Related]
13. Severe immune haemolytic anaemia due to ceftriaxone in a patient with congenital nephrotic syndrome. Reis Boto ML; Sandes AR; Brites A; Silva S; Stone R; Almeida M Acta Paediatr; 2011 Oct; 100(10):e191-3. PubMed ID: 21450013 [TBL] [Abstract][Full Text] [Related]